Brief: Reunion Neuroscience Files Lawsuit Against Mindset Pharma
13/03/2023 22:56
March 13 (Reuters) - Reunion Neuroscience Inc REUN.TO :
* REUNION NEUROSCIENCE FILES LAWSUIT AGAINST MINDSET PHARMA
* FILED A LAWSUIT AGAINST MINDSET PHARMA IN UNITED STATES
DISTRICT
COURT FOR DISTRICT OF NEW JERSEY
* FILED A LAWSUIT ALLEGING MINDSET KNOWINGLY COPIED CO'S
RE104
COMPOUND & MISLEADINGLY PRESENTED THAT EXACT COMPOSITION TO
PATENT OFFICE AS MINDSET'S INVENTION
Source text for Eikon: ID:nGNX70qYvB
Further company coverage: REUN.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindset pharma
See all newsStifel GMP sees significant uncertainty for Reunion Neuroscience over lawsuit
Brief: Reunion Neuroscience Files Lawsuit Against Mindset Pharma
Brief: Mindset Pharma announced Exclusive Licensing Agreement For Cybin To Acquire Intellectual Property Rights For Subset Of Co's Preclinical Compounds
Brief: Mindset Pharma Receives Scientific Advice From UK Regulator Facilitating Advancement Of Phase 1 First-In-Human Clinical Trial Plan
Brief: Mindset Pharma Enters Manufacturing Agreement With Leading CDMO To Produce Pharmaceutical Grade Batches Of Next-Generation Psilocybin Drug Candidate, Msp-1014